Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist

Clinical and Experimental Nephrology

Volumn 17, Issue 5, 2013, Pages 667-671

  Homma, Sakae ^a   Suzuki, Aika ^a   Sato, Keita ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

IPF; Keywords: Pulmonary fibrosis; MPA; MPO ANCA; Review; Vasculitis

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ALLERGIC RHINITIS; ANCA ASSOCIATED VASCULITIS; ASTHMA; BRONCHIECTASIS; BRONCHIOLITIS; CAPILLARITIS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHURG STRAUSS SYNDROME; DIFFUSE ALVEOLAR HEMORRHAGE; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INDICATION; DRUG MEGADOSE; EMPHYSEMA; FIBROSING ALVEOLITIS; FIBROTIC NONSPECIFIC INTERSTITIAL PNEUMONIA; FORCED VITAL CAPACITY; GRANULOMATOSIS WITH POLYANGIITIS; GRANULOMATOUS VASCULITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; INCIDENCE; KIDNEY FAILURE; LEUKOCYTOCLASTIC VASCULITIS; LOW DRUG DOSE; LUNG CAVITATION; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG HEMOSIDEROSIS; LUNG NODULE; LYMPHOID HYPERPLASIA; MICROSCOPIC POLYANGIITIS; MORTALITY; ORGANIZING PNEUMONIA; PLASMAPHERESIS; PLEURISY; PROGNOSIS; PULMONARY LIMITED MICROSCOPIC POLYANGIITIS; PULMONARY VASCULITIS; PULMONOLOGIST; REMISSION; REVIEW; SJOEGREN SYNDROME; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; USUAL INTERSTITIAL PNEUMONIA; VASCULITIS;

ADRENAL CORTEX HORMONES; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84887260185     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0710-7     Document Type: Review

References (26)

1. Gaudin PB, Askin FB, Falk RJ, et al. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol. 1995;104:7-16.
2. Sugiyama Y, Kitamura S. Antineutrophil cytoplasmic antibodies in diffuse panbronchiolitis. Respiration. 1999;66:233-5.
3. Gal AA, Salinas F, Staton GW. The clinical and pathological spectrum of antineutrophil cytoplasmic autoantibody-related pulmonary disease. A comparison between perinuclear and cytoplasmic antineutrophil cytoplasmic autoantibodies. Arch Pathol Lab Med. 1994;118:1209-14.
4. Akikusa B, Kondo Y, Irabu N, et al. Six cases of microscopic polyarteritis exhibiting acute interstitial pneumonia. Pathol Intern. 1995;45:580-8.
5. Brugiere O, Raffy O, Sleiman C, et al. Progressive obstructive lung disease associated with microscopic polyangiitis. Am J Respir Crit Care Med. 1997;155:739-42.
6. ter Maaten JC, Franssen CFM, Gans ROB, et al. Respiratory failure in ANCA-associated vasculitis. Chest. 1996;110:357-62.
7. Arimura Y, Minoshima S, Tanaka U, et al. Pulmonary involvement in patients with myeloperoxidase specific-antineutrophil cytoplasmic antibody. Ryumachi. 1995;35:46-55 (in Japanese).
8. Guillevin L, Durant-Gasselin B, Cevallos R, et al. Microscopic polyangiitis. Clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42:421-30.
9. Hogan SL, Nachman PU, Wilkman AS, et al. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:23-32.
10. Arulkumaran N, Periselneris N, Gaskin G, et al. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology. 2011;50:2035-43.
11. Tzelepis GE, Kokosi M, Tzioufas A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J. 2010;36:116-21.
12. Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology. 2004;9:190-6.
13. Shiraki A, Ando M, Shindoh J, et al. Prevalence of myeloperoxidase-anti- neutrophil cytoplasmic antibody (MPO-ANCA) in patients interstitial pneumonia. Jpn J Thorac Dis. 2007;45:921-26 (in Japanese).
14. Foulon G, Delaval P, Valeyre D, et al. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med. 2008;102:1392-8.
15. Hervier B, Pagnoux C, Agard C, et al. Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis. 2009;68:404-7.
16. Nozu T, Kondo M, Suzuki K, et al. A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration. 2009;77:407-15.
17. Suzuki A, Sato K, Isobe K, et al. Clinical characteristics in pulmonary limited MPA. Jpn J Thorac Dis. 2012;1:252 (abstract).
18. Yamada H. ANCA-associated lung fibrosis. Semin Respir Crit Care Med. 2011;32:322-7.
19. Hebisawa A, Kuramochi S, Ogura T, et al. Pathological findings in interstitial pneumonia with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Jpn J Chest Dis. 2008;67:210-9.
20. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310-7.
21. Lapraik C, Watts R, Bacon P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology. 2007;46:1615-6.
22. Japanese Respiratory Society's Committee formulating diagnosis and treatment guideline for diffuse lung diseases. Clinical diagnostic and treatment guidance for idiopathic interstitial pneumonias. Tokyo: Nankodo; 2011.
23. Ozaki S, Atsumi T, Hayashi T, et al. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol. 2012;22:394-404.
24. Harte S, Mcnicholas WT, Donnelly S, et al. Honeycomb cysts in idiopathic pulmonary haemosiderosis: high-resolution CT appearances in two adults. Br J Radiol. 2008;81:295-8.
25. Buschman DL, Ballard R. Progressive massive fibrosis associated with idiopathic pulmonary hemosiderosis. Chest. 1993;104:293-5.
26. Tomita Y, Mori S, Arima N, et al. Rapidly progressive pulmonary fibrosis following the onset of diffuse alveolar hemorrhage in Sjogren's syndrome: an autopsy case report. Intern Med. 2012;51:295-9.